MSK Announces Closing of Financing for NASDAQ Client RGDX
Mitchell, Silberberg & Knupp* announced that its client Response Genetics, Inc. (NASDAQ: RGDX) entered into and completed the initial drawdown of a $12 million credit facility from SWK Funding LLC, a wholly-owned subsidiary of SWK Holdings Corporation.
The Mitchell, Silberberg & Knupp* team was led by Co-Managing Partner, Kevin Friedmann. Response Genetics is a CLIA-certified clinical laboratory focused on the development and sale of molecular diagnostic testing services for cancer.
*Handled through the predecessor law firm of Richardson Patel LLP.